✦ LIBER ✦

Long-term maraviroc use as salvage therapy in HIV-2 infection

✍ Scribed by Caixas, U.; Ferreira, J.; Marinho, A. T.; Faustino, I.; Grilo, N. M.; Lampreia, F.; Germano, I.; Monteiro, E. C.; Pereira, S. A.

Book ID: 118744649
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 103 KB
Volume: 67
Category: Article
ISSN: 0305-7453
DOI: 10.1093/jac/dks240

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dynamics of enfuvirtide resistance in HI

Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy

✍ Eva Poveda; Berta Rodés; Sophie Lebel-Binay; Jean-Louis Faudon; Victoria Jimenez 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Foscarnet as salvage therapy in HIV-2-in

Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure

✍ Sophie Stegmann; Maria Elena Manea; Charlotte Charpentier; Florence Damond; Mari 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Long-term interleukin-2 therapy of benef

Long-term interleukin-2 therapy of benefit in patients with HIV infection

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Oral human β-defensin 2 in HIV-infected

Oral human β-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapy

✍ Wipawee Nittayananta; Marisa Kemapunmanus; Korntip Amornthatree; Sineepat Talung 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

P2.06 Salvage therapy of long term centr

P2.06 Salvage therapy of long term central venous catheters infected with Gram-negative bacteria

✍ M.B. Souza Dias; V.L. Borrasca Silva; A. Colli; M.R. Araujo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Gender and long-term metabolic toxicitie

Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons

✍ Mohamed-Rachid Boulassel; Rosa Morales; Tanya Murphy; Richard G. Lalonde; Marina 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract Gender differences in a large population‐based cohort of HIV‐1 infected patients (245 women and 723 men) were examined with respect to the incidence of metabolic and morphologic alterations after initiation of highly active antiretroviral therapy (HAART). Patients initiated HAART betwee